The Syneos Health Podcast

CORONAVIRUS SPECIAL EDITION, Episode 6: The Leader's Experience

March 30, 2020 Jeffrey Stewart
The Syneos Health Podcast
CORONAVIRUS SPECIAL EDITION, Episode 6: The Leader's Experience
Chapters
The Syneos Health Podcast
CORONAVIRUS SPECIAL EDITION, Episode 6: The Leader's Experience
Mar 30, 2020
Jeffrey Stewart

Ensuring the health and safety of the workforce – while maintaining business as usual – is a delicate balance in the face of the COVID-19 pandemic.  

In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.

Stay tuned for more installments of the Coronavirus Special Edition Series, which will explore, from an operational standpoint, the impact of COVID-19 on the biopharma industry, the challenges for rapid R&D in an outbreak environment, and the opportunities to leverage technology and innovation to address these critical issues. Additional materials and insights can also be found in our COVID-19 Resource Center.

If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision making and investment. You can find it all at insightshub.health.

Like what you’re hearing?  Be sure to rate and review us!  

We want to hear from you!  If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com

* This episode was recorded on 3/13/2020.

Show Notes

Ensuring the health and safety of the workforce – while maintaining business as usual – is a delicate balance in the face of the COVID-19 pandemic.  

In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.

Stay tuned for more installments of the Coronavirus Special Edition Series, which will explore, from an operational standpoint, the impact of COVID-19 on the biopharma industry, the challenges for rapid R&D in an outbreak environment, and the opportunities to leverage technology and innovation to address these critical issues. Additional materials and insights can also be found in our COVID-19 Resource Center.

If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision making and investment. You can find it all at insightshub.health.

Like what you’re hearing?  Be sure to rate and review us!  

We want to hear from you!  If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com

* This episode was recorded on 3/13/2020.